AU3495993A - Vaccines produced from herpes simplex virus light particles - Google Patents

Vaccines produced from herpes simplex virus light particles

Info

Publication number
AU3495993A
AU3495993A AU34959/93A AU3495993A AU3495993A AU 3495993 A AU3495993 A AU 3495993A AU 34959/93 A AU34959/93 A AU 34959/93A AU 3495993 A AU3495993 A AU 3495993A AU 3495993 A AU3495993 A AU 3495993A
Authority
AU
Australia
Prior art keywords
herpes simplex
simplex virus
light particles
vaccines produced
virus light
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU34959/93A
Inventor
Myriam Francotte
Nathalie Marie-Josephe Claude Garcon-Johnson
Jean-Paul Prieels
Moncef Slaoui
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
SmithKline Beecham Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Biologicals SA filed Critical SmithKline Beecham Biologicals SA
Publication of AU3495993A publication Critical patent/AU3495993A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
AU34959/93A 1992-02-12 1993-02-09 Vaccines produced from herpes simplex virus light particles Abandoned AU3495993A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9202933 1992-02-12
GB9202933A GB9202933D0 (en) 1992-02-12 1992-02-12 Vaccines

Publications (1)

Publication Number Publication Date
AU3495993A true AU3495993A (en) 1993-09-03

Family

ID=10710240

Family Applications (1)

Application Number Title Priority Date Filing Date
AU34959/93A Abandoned AU3495993A (en) 1992-02-12 1993-02-09 Vaccines produced from herpes simplex virus light particles

Country Status (5)

Country Link
AU (1) AU3495993A (en)
GB (1) GB9202933D0 (en)
MX (1) MX9300744A (en)
WO (1) WO1993015749A1 (en)
ZA (1) ZA93919B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9325496D0 (en) * 1993-12-14 1994-02-16 Smithkline Beecham Biolog Vaccines
ATE312189T1 (en) 2000-01-21 2005-12-15 Biovex Ltd VIRUS STRAINS FOR ONCOLYTIC TREATMENT OF CANCER
US11752206B2 (en) 2017-03-15 2023-09-12 Modernatx, Inc. Herpes simplex virus vaccine
WO2020190750A1 (en) 2019-03-15 2020-09-24 Modernatx, Inc. Hiv rna vaccines

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0089854B1 (en) * 1982-03-24 1988-12-07 The University Of Birmingham Vaccine against dna viruses
ATE70308T1 (en) * 1984-09-12 1991-12-15 Chiron Corp HYBRID PARTICLE IMMUNOGENS.
CA1331443C (en) * 1987-05-29 1994-08-16 Charlotte A. Kensil Saponin adjuvant
US4912094B1 (en) * 1988-06-29 1994-02-15 Ribi Immunochem Research Inc. Modified lipopolysaccharides and process of preparation
GB9102126D0 (en) * 1991-01-31 1991-03-13 Smithkline Beecham Biolog Novel vaccine
GB9105992D0 (en) * 1991-03-21 1991-05-08 Smithkline Beecham Biolog Vaccine
PT100460B (en) * 1991-05-07 1999-07-30 Medical Res Council PARTICLES DERIVED FROM HERPES VIRUSES AND VACCINES THAT CONTAIN THEM

Also Published As

Publication number Publication date
WO1993015749A1 (en) 1993-08-19
MX9300744A (en) 1993-09-01
ZA93919B (en) 1993-11-26
GB9202933D0 (en) 1992-03-25

Similar Documents

Publication Publication Date Title
AU3434393A (en) Targeted virus
AU4325089A (en) Viral vaccines
AU2220492A (en) Light gun
AU4092893A (en) Particle trap
AU627276B2 (en) Light system
AU4450093A (en) Hepatitis A virus vaccine
AU3468893A (en) Temporary replacement safety light system
AU5177090A (en) Optical projection system
AU7597998A (en) Herpes simplex virus vp22 vaccines and methods of use
AU3961793A (en) Virus resistant plants
AU5679394A (en) Hepatitis b virus vaccines
EP0526652A4 (en) Method of type-specific detection of herpes simplex virus
GB9304239D0 (en) Viral particles
AU3495993A (en) Vaccines produced from herpes simplex virus light particles
AU1522792A (en) Multiple hepatitis b virus surface proteins which form particles
AU3861793A (en) A light projector
AU4592293A (en) Sport-piloting aeroplane
AU4751496A (en) Herpes simplex virus mutants
HU9203976D0 (en) Vaccine based on modified herpes virus
AU4581493A (en) Electrostatic filter
AU5405794A (en) O-derivatized alginic acid antigens
AU1273495A (en) Glycoproteins from herpes virus and vaccines containing them
AU3512793A (en) Process for the expression of herpes simplex virus type 1 glycoprotein I and methods of use
AU688259B2 (en) Hepatitis C virus peptides
GB2270706B (en) Light weight beam system